Concepedia

Secil Franke-Welch

SF

2

Publications

64

Citations

2

H-Index

2017

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

Secil Franke-Welch is an author at Bristol-Myers Squibb (United States) specializing in immunology, medicine, and cancer cell biology.

ORCID

Top concepts

Publications per year

2017–2024

2

Publications

2

Drug-regulated CD33-targeted CAR T cells control AML using clinically optimized rapamycin dosing

Jacob Appelbaum, April E. Price, Kaori Oda et al. · Journal of Clinical Investigation · 2024 · 43 citations · Full text

Conditioned media from the renal cell carcinoma cell line 786.O drives human blood monocytes to a monocytic myeloid-derived suppressor cell phenotype

Shannon Okada, Randi M. Simmons, Secil Franke-Welch et al. · Cellular Immunology · 2017 · 21 citations

, , +7

Rows per page

1–2 of 2